Publications by authors named "M Zerbib"

Claim this Profile
L
Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentation.
Shira Sagie, Tomer Babu, Chen Weller, Claire Tabachnik, Ido Livneh, Mirie Zerbib

Cell Rep Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent immunogenic neoantigens and their cognate T-cell receptors in treatment-resistant metastatic prostate cancer.
Nofar Gumpert, Shira Sagie, Claudia Arnedo-Pac, Tomer Babu, Chen Weller, Mirie Zerbib

Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of eIF1A-ribosome interaction unveil uORF-dependent regulation of translation initiation and antitumor and antiviral effects.
Daniel Hayat, Ariel Ogran, Shaked Ashkenazi, Alexander Plotnikov, Roni Oren, Mirie Zerbib

EMBO J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translation dysregulation in cancer as a source for targetable antigens.
Chen Weller, Osnat Bartok, Christopher S McGinnis, Heyilimu Palashati, Tian-Gen Chang, Mirie Zerbib

Cancer Cell· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
confers resistance to antiandrogens: mechanism and therapeutic implications.
Arunachalam Sekar, Rishita Chatterjee, Boobash Raj Selvadurai, Lipika R Pal, Aakanksha Verma, Mirie Zerbib

bioRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis